Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry v3.4.2 was added to the Study Record Versions and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.4.1 is now listed. The previous government funding operating-status notice associated with v3.4.0 has been removed.SummaryDifference0.8%

- Check29 days agoChange DetectedThe update adds a glossary display and color-coded highlights for additions and deletions, plus a new revision label (v3.4.0). These are UI/formatting changes and do not affect the study data.SummaryDifference1%

- Check37 days agoChange DetectedThe Record History page shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) has been removed, reflecting a minor update to the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. These changes are cosmetic and do not alter study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedThe Record History shows a new revision entry v3.3.2 added and the prior revision v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.